<DOC>
	<DOCNO>NCT02386618</DOCNO>
	<brief_summary>Endoscopic mucosal resection ( EMR ) consider gold standard therapy colorectal lateral spreading tumor ( LST ) without significant risk lymphatic spread . According investigator previous study , local residual neoplasia ( LRN ) conventional endoscopic mucosal resection ( EMR ) occur 21 % case . Endoscopic therapy LRN sufficient 53 % standardize yet .</brief_summary>
	<brief_title>Endoscopic Treatment Local Residual Neoplasia</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>patient older 18 year patient local residual neoplasia scar three month endoscopic mucosal resection laterally spread tumor ( 0IIa &gt; 10 mm ) sign informed consent incomplete endoscopic mucosal resection previous therapy local residual neoplasia difficult impossible localization postEMR scar</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>laterally spread tumor</keyword>
	<keyword>endoscopic mucosal resestion</keyword>
	<keyword>local residual neoplasia</keyword>
</DOC>